Area of research
Cancer Research · Oncology
Research interest
Research interests include MicroRNA in disease regulation, Cancer, Lipids, and Metabolism, Pancreatic and Hepatic Oncology Research, and Cancer Cells and Metastasis.
[Corrigendum] Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer
Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer
Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1
Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl
Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cells
Quercetin-induced miRNA-X switches the mode of cancer stem cells (CSCs) division and inhibits CSCs like features in pancreatic cancer
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine
Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication
Triptolide reverses hypoxia‐induced epithelial–mesenchymal transition and stem‐like features in pancreatic cancer by NF‐κB downregulation
The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer